117 related articles for article (PubMed ID: 2767242)
21. Opsonic and antibody responses to pneumococcal polysaccharide types 6A, 19F and 23F after vaccination of immunocompromised patients.
Braconier JH; Pedersen FK; Odeberg H; Rosén C
Scand J Infect Dis; 1984; 16(2):161-7. PubMed ID: 6740247
[TBL] [Abstract][Full Text] [Related]
22. Antibody response to pneumococcal vaccine in splenectomized adults and adolescents.
Pedersen FK; Nielsen JL; Ellegaard J
Acta Pathol Microbiol Immunol Scand C; 1982 Oct; 90(5):257-63. PubMed ID: 6891169
[TBL] [Abstract][Full Text] [Related]
23. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
[TBL] [Abstract][Full Text] [Related]
24. Reactivity and antibody responses of volunteers given two or three doses of pneumococcal vaccine.
Mufson MA; Krause HE; Schiffman G
Proc Soc Exp Biol Med; 1984 Nov; 177(2):220-5. PubMed ID: 6483857
[TBL] [Abstract][Full Text] [Related]
25. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease.
Siber GR; Weitzman SA; Aisenberg AC; Weinstein HJ; Schiffman G
N Engl J Med; 1978 Aug; 299(9):442-8. PubMed ID: 28483
[TBL] [Abstract][Full Text] [Related]
26. Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease.
Siber GR; Gorham C; Martin P; Corkery JC; Schiffman G
Ann Intern Med; 1986 Apr; 104(4):467-75. PubMed ID: 3082268
[TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin classes and persistence of anti-pneumococcal antibodies in splenectomized adults and adolescents after pneumococcal vaccination.
Pedersen FK; Nielsen JL; Ellegaard J
Acta Pathol Microbiol Immunol Scand C; 1983 Aug; 91(4):245-9. PubMed ID: 6637480
[TBL] [Abstract][Full Text] [Related]
28. IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise normal, individuals.
Aaberge IS; Michaelsen TE; Heier HE
Scand J Immunol; 1990 Jun; 31(6):711-6. PubMed ID: 2356437
[TBL] [Abstract][Full Text] [Related]
29. Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine.
Hosea SW; Burch CG; Brown EJ; Berg RA; Frank MM
Lancet; 1981 Apr; 1(8224):804-7. PubMed ID: 6111673
[TBL] [Abstract][Full Text] [Related]
30. [Antibody response to pneumococcal polysaccharide antigens following splenectomy and replantation of autologous splenic tissue].
Sklenar I; Dürig M; Lydick E; Erb P; Harder F
Aktuelle Probl Chir Orthop; 1985; 30():107-12. PubMed ID: 2867694
[No Abstract] [Full Text] [Related]
31. Pneumococcal revaccination of splenectomized children.
Konradsen HB; Pedersen FK; Henrichsen J
Pediatr Infect Dis J; 1990 Apr; 9(4):258-63. PubMed ID: 2336311
[TBL] [Abstract][Full Text] [Related]
32. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly.
Sankilampi U; Honkanen PO; Bloigu A; Herva E; Leinonen M
J Infect Dis; 1996 Feb; 173(2):387-93. PubMed ID: 8568300
[TBL] [Abstract][Full Text] [Related]
33. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination.
Koskela M
Pediatr Infect Dis J; 1987 Jun; 6(6):519-26. PubMed ID: 3615065
[TBL] [Abstract][Full Text] [Related]
34. Pneumococcal vaccine failure in a splenectomized child.
Koren A; Efrati Z; Algazi J; Katzuni E
Infect Control; 1984 Dec; 5(12):556. PubMed ID: 6569852
[No Abstract] [Full Text] [Related]
35. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations.
Sorensen RU; Leiva LE; Javier FC; Sacerdote DM; Bradford N; Butler B; Giangrosso PA; Moore C
J Allergy Clin Immunol; 1998 Aug; 102(2):215-21. PubMed ID: 9723664
[TBL] [Abstract][Full Text] [Related]
36. Timing of vaccination does not affect antibody response or survival after pneumococcal challenge in splenectomized rats.
Schreiber MA; Pusateri AE; Veit BC; Smiley RA; Morrison CA; Harris RA
J Trauma; 1998 Oct; 45(4):692-7; discussion 697-9. PubMed ID: 9783606
[TBL] [Abstract][Full Text] [Related]
37. Impaired response to pneumococcal vaccine in Hodgkin's disease.
Cadman E; Cohen MS; Root RK; Ryan JL; Minor DR
N Engl J Med; 1978 Dec; 299(23):1317-8. PubMed ID: 30897
[No Abstract] [Full Text] [Related]
38. Response of traumatized splenectomized patients to immediate vaccination with polyvalent pneumococcal vaccine.
Caplan ES; Boltansky H; Snyder MJ; Rooney J; Hoyt NJ; Schiffman G; Cowley RA
J Trauma; 1983 Sep; 23(9):801-5. PubMed ID: 6620433
[TBL] [Abstract][Full Text] [Related]
39. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults.
Coughlin RT; White AC; Anderson CA; Carlone GM; Klein DL; Treanor J
Vaccine; 1998 Nov; 16(18):1761-7. PubMed ID: 9778753
[TBL] [Abstract][Full Text] [Related]
40. Antibody response of pneumococcal vaccine: need for booster dosing?
Mufson MA
Int J Antimicrob Agents; 2000 Mar; 14(2):107-12. PubMed ID: 10720799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
